91 related articles for article (PubMed ID: 12879010)
1. Downregulation of stomach cancer-associated protein tyrosine phosphatase-1 (SAP-1) in advanced human hepatocellular carcinoma.
Nagano H; Noguchi T; Inagaki K; Yoon S; Matozaki T; Itoh H; Kasuga M; Hayashi Y
Oncogene; 2003 Jul; 22(30):4656-63. PubMed ID: 12879010
[TBL] [Abstract][Full Text] [Related]
2. Expression of cyclooxygenase-2 in human hepatocellular carcinoma: relevance to tumor dedifferentiation.
Koga H; Sakisaka S; Ohishi M; Kawaguchi T; Taniguchi E; Sasatomi K; Harada M; Kusaba T; Tanaka M; Kimura R; Nakashima Y; Nakashima O; Kojiro M; Kurohiji T; Sata M
Hepatology; 1999 Mar; 29(3):688-96. PubMed ID: 10051469
[TBL] [Abstract][Full Text] [Related]
3. Expression of Id proteins in human hepatocellular carcinoma: relevance to tumor dedifferentiation.
Damdinsuren B; Nagano H; Kondo M; Yamamoto H; Hiraoka N; Yamamoto T; Marubashi S; Miyamoto A; Umeshita K; Dono K; Nakamori S; Wakasa K; Sakon M; Monden M
Int J Oncol; 2005 Feb; 26(2):319-27. PubMed ID: 15645115
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of SAP-1, a transmembrane-type protein tyrosine phosphatase, in human colorectal cancers.
Seo Y; Matozaki T; Tsuda M; Hayashi Y; Itoh H; Kasuga M
Biochem Biophys Res Commun; 1997 Feb; 231(3):705-11. PubMed ID: 9070877
[TBL] [Abstract][Full Text] [Related]
5. Comparison study of the expressions of myristoylated alanine-rich C kinase substrate in hepatocellular carcinoma, liver cirrhosis, chronic hepatitis, and normal liver.
Masaki T; Tokuda M; Yoshida S; Nakai S; Morishita A; Uchida N; Funaki T; Kita Y; Funakoshi F; Nonomura T; Himoto T; Deguchi A; Kimura Y; Izuishi K; Wakabayashi H; Usuki H; Yoshiji H; Watanabe S; Kurokohchi K; Kuriyama S
Int J Oncol; 2005 Mar; 26(3):661-71. PubMed ID: 15703821
[TBL] [Abstract][Full Text] [Related]
6. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China.
Dong-Dong L; Xi-Ran Z
Hepatogastroenterology; 2004; 51(56):515-25. PubMed ID: 15086194
[TBL] [Abstract][Full Text] [Related]
7. Down-regulated expression of the protein-tyrosine phosphatase 1B (PTP1B) is associated with aggressive clinicopathologic features and poor prognosis in hepatocellular carcinoma.
Zheng LY; Zhou DX; Lu J; Zhang WJ; Zou DJ
Biochem Biophys Res Commun; 2012 Apr; 420(3):680-4. PubMed ID: 22450318
[TBL] [Abstract][Full Text] [Related]
8. DDX3, a DEAD box RNA helicase, is deregulated in hepatitis virus-associated hepatocellular carcinoma and is involved in cell growth control.
Chang PC; Chi CW; Chau GY; Li FY; Tsai YH; Wu JC; Wu Lee YH
Oncogene; 2006 Mar; 25(14):1991-2003. PubMed ID: 16301996
[TBL] [Abstract][Full Text] [Related]
9. High-throughput tissue microarray analysis of c-myc activation in chronic liver diseases and hepatocellular carcinoma.
Chan KL; Guan XY; Ng IO
Hum Pathol; 2004 Nov; 35(11):1324-31. PubMed ID: 15668888
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of extracellular signal-regulated protein kinase and its correlation with proliferation in human hepatocellular carcinoma.
Tsuboi Y; Ichida T; Sugitani S; Genda T; Inayoshi J; Takamura M; Matsuda Y; Nomoto M; Aoyagi Y
Liver Int; 2004 Oct; 24(5):432-6. PubMed ID: 15482339
[TBL] [Abstract][Full Text] [Related]
11. ARHI, as a novel suppressor of cell growth and downregulated in human hepatocellular carcinoma, could contribute to hepatocarcinogenesis.
Huang J; Lin Y; Li L; Qing D; Teng XM; Zhang YL; Hu X; Hu Y; Yang P; Han ZG
Mol Carcinog; 2009 Feb; 48(2):130-40. PubMed ID: 18612997
[TBL] [Abstract][Full Text] [Related]
12. Involvement of RhoA in progression of human hepatocellular carcinoma.
Wang D; Dou K; Xiang H; Song Z; Zhao Q; Chen Y; Li Y
J Gastroenterol Hepatol; 2007 Nov; 22(11):1916-20. PubMed ID: 17914970
[TBL] [Abstract][Full Text] [Related]
13. IGFBP-3 expression in hepatocellular carcinoma involves abnormalities in TGF-beta and/or Rb signaling pathways.
Yumoto E; Nakatsukasa H; Hanafusa T; Yumoto Y; Nouso K; Matsumoto E; Onishi T; Takuma Y; Tanaka H; Fujikawa T; Suzuki M; Uemura M; Shiratori Y
Int J Oncol; 2005 Nov; 27(5):1223-30. PubMed ID: 16211216
[TBL] [Abstract][Full Text] [Related]
14. Wilms' tumor 1 gene expression in hepatocellular carcinoma promotes cell dedifferentiation and resistance to chemotherapy.
Perugorria MJ; Castillo J; Latasa MU; Goñi S; Segura V; Sangro B; Prieto J; Avila MA; Berasain C
Cancer Res; 2009 Feb; 69(4):1358-67. PubMed ID: 19190340
[TBL] [Abstract][Full Text] [Related]
15. Relationship between elevated FX expression and increased production of GDP-L-fucose, a common donor substrate for fucosylation in human hepatocellular carcinoma and hepatoma cell lines.
Noda K; Miyoshi E; Gu J; Gao CX; Nakahara S; Kitada T; Honke K; Suzuki K; Yoshihara H; Yoshikawa K; Kawano K; Tonetti M; Kasahara A; Hori M; Hayashi N; Taniguchi N
Cancer Res; 2003 Oct; 63(19):6282-9. PubMed ID: 14559815
[TBL] [Abstract][Full Text] [Related]
16. Identification of c-Yes expression in the nuclei of hepatocellular carcinoma cells: involvement in the early stages of hepatocarcinogenesis.
Nonomura T; Masaki T; Morishita A; Jian G; Uchida N; Himoto T; Izuishi K; Iwama H; Yoshiji H; Watanabe S; Kurokohchi K; Kuriyama S
Int J Oncol; 2007 Jan; 30(1):105-11. PubMed ID: 17143518
[TBL] [Abstract][Full Text] [Related]
17. Reduction of double-stranded RNA-activated protein kinase in hepatocellular carcinoma associated with hepatitis B virus.
Chen GG; Lai PB; Ho RL; Chan PK; Xu H; Wong J; Lau WY
J Med Virol; 2004 Jun; 73(2):187-94. PubMed ID: 15122791
[TBL] [Abstract][Full Text] [Related]
18. The selective reduction in PTPdelta expression in hepatomas.
Urushibara N; Karasaki H; Nakamura K; Mizuno Y; Ogawa K; Kikuchi K
Int J Oncol; 1998 Mar; 12(3):603-7. PubMed ID: 9472099
[TBL] [Abstract][Full Text] [Related]
19. Bone morphogenetic protein 4 is induced in hepatocellular carcinoma by hypoxia and promotes tumour progression.
Maegdefrau U; Amann T; Winklmeier A; Braig S; Schubert T; Weiss TS; Schardt K; Warnecke C; Hellerbrand C; Bosserhoff AK
J Pathol; 2009 Aug; 218(4):520-9. PubMed ID: 19431154
[TBL] [Abstract][Full Text] [Related]
20. Involvement of programmed cell death 4 in transforming growth factor-beta1-induced apoptosis in human hepatocellular carcinoma.
Zhang H; Ozaki I; Mizuta T; Hamajima H; Yasutake T; Eguchi Y; Ideguchi H; Yamamoto K; Matsuhashi S
Oncogene; 2006 Oct; 25(45):6101-12. PubMed ID: 16682950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]